Bengt Glimelius

Top papers

• Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

  Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal, et al.·2001·New England Journal of Medicine
  ↗ 4,208OA
• A pathology atlas of the human cancer transcriptome

  Mathias Uhlén, Cheng Zhang, Sunjae Lee, et al.·2017·Science
  ↗ 3,467OA
• Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

  Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius, et al.·2008·The Lancet
  ↗ 1,938OA
• Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

  John P. Neoptolemos, Daniel H. Palmer, Paula Ghaneh, et al.·2017·The Lancet
  ↗ 1,914OA
• Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

  W. van Gijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal, et al.·2011·The Lancet Oncology
  ↗ 1,895
• Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

  Bengt Glimelius, Emmanuel Tiret, Andrés Cervantes, et al.·2013·Annals of Oncology
  ↗ 1,784OA
• A Prognostic Score for Advanced Hodgkin's Disease

  Dirk Hasenclever, Volker Diehl, Jamés O. Armitage, et al.·1998·New England Journal of Medicine
  ↗ 1,726OA
• Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

  Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten, et al.·2020·The Lancet Oncology
  ↗ 1,574OA
• ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

  Hans‐Joachim Schmoll, Eric Van Cutsem, Alexander Stein, et al.·2012·Annals of Oncology
  ↗ 1,527OA
• Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

  Bernard Nordlinger, Halfdan Sørbye, Bengt Glimelius, et al.·2013·The Lancet Oncology
  ↗ 1,308
• The TME Trial After a Median Follow-up of 6 Years

  Koen Peeters, Corrie A.M. Marijnen, Irıs D. Nagtegaal, et al.·2007·Annals of Surgery
  ↗ 1,191
• Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

  Pascal Hammel, F. Huguet, Jean‐Luc Van Laethem, et al.·2016·JAMA
  ↗ 1,055